Nanogen, Inc., developer of molecular diagnostic products for the gene-based testing market, and SYN X Pharma, Inc, a point-of-care diagnostics company, announced today the signing of a definitive ...

Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., /PRNewswire/ -- CND Life Sciences (CND) ...